MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

Search

Penumbra Inc

Chiusa

SettoreSettore sanitario

250.63 -2.09

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

245.7

Massimo

255.67

Metriche Chiave

By Trading Economics

Entrata

5.5M

39M

Vendite

8.6M

324M

P/E

Media del settore

237.62

40.527

EPS

0.83

Margine di Profitto

12.101

Dipendenti

4,500

EBITDA

131K

49M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+24.53% upside

Dividendi

By Dow Jones

Utili prossimi

29 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-791M

9.9B

Apertura precedente

252.72

Chiusura precedente

250.63

Notizie sul Sentiment di mercato

By Acuity

50%

50%

163 / 380 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

Penumbra Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

1 lug 2025, 23:09 UTC

Utili

Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update

1 lug 2025, 19:16 UTC

Acquisizioni, Fusioni, Takeovers

Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander

1 lug 2025, 23:47 UTC

Discorsi di Mercato

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

1 lug 2025, 23:41 UTC

Discorsi di Mercato

Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk

1 lug 2025, 22:23 UTC

Acquisizioni, Fusioni, Takeovers

James Hardie: Deal Represents Implied Value of $8.4 Billion

1 lug 2025, 22:23 UTC

Acquisizioni, Fusioni, Takeovers

James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share

1 lug 2025, 22:21 UTC

Acquisizioni, Fusioni, Takeovers

James Hardie Completes Acquisition of AZEK

1 lug 2025, 20:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

1 lug 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

1 lug 2025, 20:24 UTC

Utili

Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com

1 lug 2025, 19:55 UTC

Discorsi di Mercato

Oil Futures Resume Cautious Rally -- Market Talk

1 lug 2025, 19:27 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Lose More Ground -- Market Talk

1 lug 2025, 19:12 UTC

Discorsi di Mercato

Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk

1 lug 2025, 19:01 UTC

Acquisizioni, Fusioni, Takeovers

Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander

1 lug 2025, 18:41 UTC

Acquisizioni, Fusioni, Takeovers

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

1 lug 2025, 18:33 UTC

Discorsi di Mercato

Market Talk Roundup: Latest on U.S. Politics

1 lug 2025, 18:33 UTC

Discorsi di Mercato

Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk

1 lug 2025, 18:32 UTC

Discorsi di Mercato

Mexico Manufacturing PMIs Remain Weak in June -- Market Talk

1 lug 2025, 18:22 UTC

Discorsi di Mercato

Remittances to Mexico Down in May -- Market Talk

1 lug 2025, 17:45 UTC

Discorsi di Mercato

Seasonal Demand Supports Further Oil Gains -- Market Talk

1 lug 2025, 17:01 UTC

Acquisizioni, Fusioni, Takeovers

Danone Completed Acquisition of Majority Stake in Kate Farms

1 lug 2025, 16:55 UTC

Utili

10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com

1 lug 2025, 16:27 UTC

Discorsi di Mercato

Trade Concerns Ease in Bank of Mexico Survey -- Market Talk

1 lug 2025, 16:25 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk

1 lug 2025, 16:20 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

1 lug 2025, 15:48 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk

1 lug 2025, 15:46 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

1 lug 2025, 15:46 UTC

Discorsi di Mercato

Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk

1 lug 2025, 14:54 UTC

Discorsi di Mercato

Thales Expected to Stick to This Year's Sales Guidance -- Market Talk

1 lug 2025, 14:49 UTC

Discorsi di Mercato

Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk

Confronto tra pari

Modifica del prezzo

Penumbra Inc Previsione

Obiettivo di Prezzo

By TipRanks

24.53% in crescita

Previsioni per 12 mesi

Media 319.58 USD  24.53%

Alto 340 USD

Basso 260 USD

Basato su 16 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Penumbra Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

16 ratings

12

Acquista

4

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

288.28 / 292.9394Supporto e resistenza

A breve termine

Bearish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Weak Bullish Evidence

Sentiment

By Acuity

163 / 380 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.